Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Endocrine Gland Neoplasms
Diseases [C] » Endocrine System Diseases [C19] » Endocrine Gland Neoplasms
Description
Tumors or cancer of the ENDOCRINE GLANDS. MeSH
Hierarchy View
Subtype Terms (9)
Adrenal Gland Neoplasms
45 drugs (32 approved, 13 experimental)
Multiple Endocrine Neoplasia
6 drugs (5 approved, 1 experimental)
Ovarian Neoplasms
995 drugs (273 approved, 722 experimental)
Pancreatic Neoplasms
1165 drugs (343 approved, 822 experimental)
Paraneoplastic Endocrine Syndromes
Parathyroid Neoplasms
15 drugs (12 approved, 3 experimental)
Pituitary Neoplasms
43 drugs (33 approved, 10 experimental)
Testicular Neoplasms
142 drugs (92 approved, 50 experimental)
Thyroid Neoplasms
239 drugs (140 approved, 99 experimental)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (7)
Phase 1 Indicated Drugs (3)
Organization Involved with Phase 4 Indications (4)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (25)
Organization Involved with Phase 1 Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
